Cargando…
Anti-seed PNAs targeting multiple oncomiRs for brain tumor therapy
Glioblastoma (GBM) is one of the most lethal malignancies with poor survival and high recurrence rates. Here, we aimed to simultaneously target oncomiRs 10b and 21, reported to drive GBM progression and invasiveness. We designed short (8-mer) γ-modified peptide nucleic acids (sγPNAs), targeting the...
Autores principales: | Wang, Yazhe, Malik, Shipra, Suh, Hee-Won, Xiao, Yong, Deng, Yanxiang, Fan, Rong, Huttner, Anita, Bindra, Ranjit S., Singh, Vijender, Saltzman, W. Mark, Bahal, Raman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9908025/ https://www.ncbi.nlm.nih.gov/pubmed/36753549 http://dx.doi.org/10.1126/sciadv.abq7459 |
Ejemplares similares
-
OncomiRs: the discovery and progress of microRNAs in cancers
por: Cho, William CS
Publicado: (2007) -
Down-regulation of traditional oncomiRs in plasma of breast cancer patients
por: Jurkovicova, Dana, et al.
Publicado: (2017) -
OMCD: OncomiR Cancer Database
por: Sarver, Aaron L., et al.
Publicado: (2018) -
MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment
por: Banno, Kouji, et al.
Publicado: (2014) -
OncomiRs as noncoding RNAs having functions in cancer: Their role in immune suppression and clinical implications
por: Otmani, Khalid, et al.
Publicado: (2022)